Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 10, Pages 457-461
http://dx.doi.org/10.1100/tsw.2010.49
Mini-Review Article

Hepatocyte Growth Factor in Synaptic Plasticity and Alzheimer's Disease

National Brain Research Centre, Manesar, Haryana-122050, India

Received 13 October 2009; Revised 27 February 2010; Accepted 1 March 2010

Academic Editor: Rudy Tanzi

Copyright © 2010 Shiv K. Sharma.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • John W. Wright, and Joseph W. Harding, “Brain renin-angiotensin-A new look at an old system,” Progress in Neurobiology, vol. 95, no. 1, pp. 49–67, 2011. View at Publisher · View at Google Scholar
  • John W. Wright, and Joseph W. Harding, “The brain renin–angiotensin system: a diversity of functions and implications for CNS diseases,” Pflügers Archiv - European Journal of Physiology, vol. 465, no. 1, pp. 133–151, 2012. View at Publisher · View at Google Scholar
  • John W. Wright, and Joseph W. Harding, “Importance of the Brain Angiotensin System in Parkinson’s Disease,” Parkinson's Disease, vol. 2012, pp. 1–14, 2012. View at Publisher · View at Google Scholar
  • M. Hokama, S. Oka, J. Leon, T. Ninomiya, H. Honda, K. Sasaki, T. Iwaki, T. Ohara, T. Sasaki, F. M. LaFerla, Y. Kiyohara, and Y. Nakabeppu, “Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study,” Cerebral Cortex, 2013. View at Publisher · View at Google Scholar
  • Kathie L. Eagleson, Teresa A. Milner, Zhihui Xie, and Pat Levitt, “Synaptic and extrasynaptic location of the receptor tyrosine kinase met during postnatal development in the mouse neocortex and hippocampus,” Journal of Comparative Neurology, vol. 521, no. 14, pp. 3241–3259, 2013. View at Publisher · View at Google Scholar
  • John W. Wright, Leen H. Kawas, and Joseph W. Harding, “The development of small molecule angiotensin IV analogues to treat Alzheimer's and Parkinson's diseases,” Progress in Neurobiology, 2014. View at Publisher · View at Google Scholar
  • Hideomi Hamasaki, Hiroyuki Honda, Satoshi O. Suzuki, Masaaki Hokama, Yutaka Kiyohara, Yusaku Nakabeppu, and Toru Iwaki, “Down-regulation of MET in hippocampal neurons of Alzheimer's disease brains,” Neuropathology, 2014. View at Publisher · View at Google Scholar
  • John A. Kessler, A. Gordon Smith, Bong-Soo Cha, Sung Hee Choi, James Wymer, Aziz Shaibani, and Senda Ajroud-Driss, “Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy,” Annals of Clinical and Translational Neurology, 2015. View at Publisher · View at Google Scholar
  • John W. Wright, and Joseph W. Harding, “The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease,” Journal Of Alzheimers Disease, vol. 45, no. 4, pp. 985–1000, 2015. View at Publisher · View at Google Scholar
  • Eva Bagyinszky, Vo Van Giau, Kyuhwan Shim, Kyoungho Suk, Seong Soo A. An, and SangYun Kim, “Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis,” Journal of the Neurological Sciences, vol. 376, pp. 242–254, 2017. View at Publisher · View at Google Scholar